Dilazep dihydrochloride is the dihydrochloride salt of dilazep. It inhibits adenosine uptake, ischemic damage, platelet aggregation, and membrane transport of nucleosides. Among its listed roles, it functions as a vasodilator agent, a platelet aggregation inhibitor and a cardioprotective agent. It includes a dilazep(2+). It is grouped under the following drug class(es): Vasodilating agents. Its therapeutic use is listed as angina. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Dilazep hydrochloride hydrate, Labitan and Cormelian. Its PubChem CID is 6419915.
Dilazep dihydrochloride
| CAS No | 20153-98-4 |
|---|---|
| Molecular Formula | C31H46Cl2N2O10 |
| Molecular Weight | 677.6 g/mol |
| Synonyms | 3-[4-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoate;dihydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dilazep dihydrochloride is the dihydrochloride salt of dilazep. It inhibits adenosine uptake, ischemic damage, platelet aggregation, and membrane transport of nucleosides.
The listed CAS number is 20153-98-4.
The listed molecular formula is C31H46Cl2N2O10.
The listed molecular weight is 677.6 g/mol.
3-[4-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]-1,4-diazepan-1-yl]propyl 3,4,5-trimethoxybenzoate;dihydrochloride.
The source lists Dilazep hydrochloride hydrate, Labitan and Cormelian.